Mr Hao-Wen Sim
Conjoint Senior Lecturer

Mr Hao-Wen Sim

MBBS(Hons) BMedSci MBiostat FRACP GStat

Medicine & Health
School of Clinical Medicine

Associate Professor Hao-Wen Sim contributes his expertise and leadership in neuro-oncology, trial methodology and biostatistics.

Hao-Wen received his medical degree with Honours from The University of Melbourne, being awarded the James Stewart Bequest for Surgery and inducted to the Margaret Whyte Honour Board. He completed his Master of Biostatistics from The University of Sydney, being awarded the Biostatistics Collaboration of Australia Star Graduate Award, Judy Simpson Biostatistics Scholarship, Les Irwig General Epidemiology Award and Australasian Epidemiological Association Top Student Prize. He also completed neuro-oncology fellowship at The Princess Margaret Cancer Centre in Toronto, Canada. He is a Fellow of The Royal Australasian College of Physicians and a graduate biostatistician of the Statistical Society of Australia.

Hao-Wen works as a lead clinician treating brain cancer patients at The Kinghorn Cancer Centre and Chris O’Brien Lifehouse in Sydney, Australia. He is the Clinical Lead of the Cooperative Trials Group for Neuro-Oncology (COGNO) and Chair of the COGNO International Clinical Research Subcommittee. His research focus is the development and conduct of investigator-initiated brain cancer trials.

Phone
+61 2 9355 5737
Location
The Kinghorn Cancer Centre, 370 Victoria St, Darlinghurst NSW 2010
  • Journal articles | 2021
    Field KM; Barnes EH; Sim HW; Nowak AK; Simes J; Rosenthal MA; Wheeler H; Hovey EJ; Cher LM, 2021, 'Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trial', Journal of Clinical Neuroscience, vol. 94, pp. 321 - 327, http://dx.doi.org/10.1016/j.jocn.2021.10.022
    Journal articles | 2018
    Natori A; Chan BA; Sim HW; Ma L; Yokom DW; Chen E; Liu G; Darling G; Swallow C; Brar S; Brierley J; Ringash J; Wong R; Kim J; Rogalla P; Hafezi-Bakhtiari S; Conner J; Knox J; Elimova E; Jang RW, 2018, 'Outcomes by treatment modality in elderly patients with localized gastric and esophageal cancer', Current Oncology, vol. 25, pp. 366 - 370, http://dx.doi.org/10.3747/co.25.4208
    Journal articles | 2018
    Samawi HH; Sim HW; Chan KK; Alghamdi MA; Lee-Ying RM; Knox JJ; Gill P; Romagnino A; Batuyong E; Ko YJ; Davies JM; Lim HJ; Cheung WY; Tam VC, 2018, 'Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database', Cancer Medicine, vol. 7, pp. 2816 - 2825, http://dx.doi.org/10.1002/cam4.1493
    Journal articles | 2018
    Sim HW; Knox J, 2018, 'Hepatocellular carcinoma in the era of immunotherapy', Current Problems in Cancer, vol. 42, pp. 40 - 48, http://dx.doi.org/10.1016/j.currproblcancer.2017.10.007
    Journal articles | 2017
    Lalani AKA; Li H; Heng DYC; Wood L; Kalirai A; Bjarnason GA; Sim HW; Kollmannsberger CK; Kapoor A; Hotte SJ; Vanhuyse M; Czaykowski P; Reaume MN; Soulieres D; Venner P; North S; Basappa NS, 2017, 'First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience', Journal of the Canadian Urological Association, vol. 11, pp. 112 - 117, http://dx.doi.org/10.5489/cuaj.4398
    Journal articles | 2014
    Sim HW; Morris PG; Patil S; Khasraw M, 2014, 'Brain metastases in breast cancer', Expert Review of Anticancer Therapy, vol. 14, pp. 173 - 183, http://dx.doi.org/10.1586/14737140.2014.863468